Acadian Asset Management LLC Myriad Genetics Inc Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$24.13 - $32.63 $65,464 - $88,525	-2,713 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$29.97 - $36.66 $81,308 - $99,458	2,713 New	2,713 $85,000
Q2 2021 Aug 11, 2021	SELL	$25.39 - $32.61 $1.21 Million - $1.56 Million	-47,802 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$19.92 - $31.6 $5.14 Million - $8.15 Million	-257,999 Reduced 84.37%	47,802 $1.46 Million
Q3 2020 Nov 09, 2020	SELL	$11.25 - $14.75 $2.34 Million - $3.07 Million	-208,293 Reduced 40.52%	305,801 $3.99 Million
Q2 2020 Aug 12, 2020	SELL	$10.69 - $16.49 $713,931 - $1.1 Million	-66,785 Reduced 11.5%	514,094 $5.83 Million
Q1 2020 May 11, 2020	SELL	$9.78 - $29.53 $2.08 Million - $6.27 Million	-212,294 Reduced 26.77%	580,879 $8.31 Million
Q4 2019 Feb 06, 2020	SELL	$20.93 - $35.1 $658,143 - $1.1 Million	-31,445 Reduced 3.81%	793,173 $21.6 Million
Q3 2019 Nov 07, 2019	SELL	$22.08 - $47.08 $10.5 Million - $22.4 Million	-474,756 Reduced 36.54%	824,618 $23.6 Million
Q2 2019 Aug 08, 2019	SELL	$22.67 - $35.0 $4.7 Million - $7.25 Million	-207,210 Reduced 13.75%	1,299,374 $36.1 Million
Q1 2019 May 09, 2019	SELL	$26.93 - $34.7 $9.58 Million - $12.3 Million	-355,695 Reduced 19.1%	1,506,584 $50 Million
Q4 2018 Feb 07, 2019	SELL	$27.23 - $45.56 $14.3 Million - $23.9 Million	-524,887 Reduced 21.99%	1,862,279 $54.1 Million
Q3 2018 Oct 30, 2018	BUY	$37.57 - $50.34 $2.23 Million - $2.99 Million	59,446 Added 2.55%	2,387,166 $110 Million
Q2 2018 Jul 24, 2018	SELL	$27.75 - $40.17 $1.47 Million - $2.13 Million	-53,062 Reduced 2.23%	2,327,720 $87 Million
Q1 2018 Apr 12, 2018	BUY	$28.83 - $41.01 $5.06 Million - $7.2 Million	175,485 Added 7.96%	2,380,782 $70.4 Million
Q4 2017 Jan 18, 2018	BUY	$28.45 - $37.14 $9.76 Million - $12.7 Million	343,196 Added 18.43%	2,205,297 $75.7 Million
Q3 2017 Oct 13, 2017	BUY	$24.01 - $36.2 $44.7 Million - $67.4 Million	1,862,101	1,862,101 $67.4 Million

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.9M

Call Options Held

100K

Put Options Held

34K

Black Rock Inc. New York, NY

15.2M
Shares

$235 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.3M
Shares

$160 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

6.72M
Shares

$104 Million
0.03% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

5.18M
Shares

$80.2 Million
0.07% of portfolio
State Street Corp Boston, MA

4.7M
Shares

$72.9 Million
0.01% of portfolio

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account